Japan, Oct. 30 -- BIONTECH SE,ASTELLAS PHARMA INC,TRON- TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ GEMEINNUETZIGE GMBH has got intellectual property rights for 'DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS.' Other related details are as follows:
Application Number: JP,2024-174919
Category (FI): A61K31/282,A61K31/337,A61K31/4725,A61K31/4745,A61K31/537,A61K31/704,A61K31/7048,A61K31/7068,A61K33/243,A61K35/12,A61K38/07,A61K38/08,A61K38/14,A61K39/395@L,A61K39/395@T,A61K45/00,A61K47/68,A61K48/00,A61K51/10,100,A61P35/00,A61P35/04,A61P43/00,121,C07K16/30,C12N5/095,C12Q1/04,G01N33/574@D,G01N33/57505,G01N33/5751,G01N33/57515,G01N33/5752,G01N33/57525,G01N33/5753,G01N33/57535,G01N33/5754,G01N33/57545,G01N33/5755,G01N33/57555,G01N33/575@D
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 4, 2024
Publication Date: Jan. 23, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
